Internal report on J&J quality meltdown due this month; 3PL Triplefin chooses Manhattan for new DCs;

> A J&J internal report of Tylenol manufacturing problems over the past year should be completed later this month, says CEO Bill Weldon. Article (registration required)

> Third party logistics provider Triplefin has implemented the SCALE (Supply Chain Architected for Logistics Execution) solutions from Manhattan Associates at two new distribution centers in Cincinnati. Triplefin release

> DSM Pharma Chemicals has launched the InnoSyn manufacturing route scouting services to help clients achieve cost savings by reducing synthesis steps and redesigning synthesis routes. DSM release

> AstraZeneca has tapped Aurobindo Pharma to supply solid dosage and sterile products for emerging markets. Item 

> Drug formulator Bend Research is expanding its manufacturing capabilities for hot-melt extrusion. Bend Research release

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.